(Q34604521)

3 August 2017

1 reference

title

Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress (English)

1 reference

3 August 2017

1 reference

Woulfe JM

1

1 reference

PubMed ID

17239006

3 August 2017

language of work or name

1 reference

1 February 2007

1 reference

Neuropathology and Applied Neurobiology

3 August 2017

1 reference

3 August 2017

33

1 reference

3 August 2017

1

1 reference

3 August 2017

2-42

1 reference

Polyglutamines placed into context

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Oculopharyngeal muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Adult-onset neuronal intranuclear hyaline inclusion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Update on the neuropathological diagnosis of frontotemporal dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

alpha-Synuclein forms a complex with transcription factor Elk-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Structural and functional heterogeneity of nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

An Alzheimer's disease hypothesis based on transcriptional dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brain-stem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00819.X

SUMO and transcriptional regulation

21 January 2018

1 reference

2 April 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.SEMCDB.2003.12.001

p300 Transcriptional Repression Is Mediated by SUMO Modification

1 reference

2 April 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S1097-2765(03)00141-2

Identifiers

DOI

10.1111/J.1365-2990.2006.00819.X

1 reference

3 August 2017

1 reference

PubMed ID

17239006